Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

BRO

Analyzing the Market Trends of BRO Stock

Now trading at a price of $80.44, Brown & Brown has moved -2.4% so far today.

Brown & Brown returned losses of -22.2% last year, with its stock price reaching a high of $125.68 and a low of $79.85. Over the same period, the stock underperformed the S&P 500 index by -40.7%. AThe company's 50-day average price was $93.13. Brown & Brown, Inc. markets and sells insurance products and services in the United States, Canada, Ireland, the United Kingdom, and internationally. Based in Daytona Beach, FL, the Large-Cap Finance company has 23,000 full time employees. Brown & Brown has offered a 0.2% dividend yield over the last 12 months.

Strong Revenue Growth but an Average Current Ratio:

2019 2020 2021 2022 2023 2024
Revenue (M) $2,392 $2,613 $3,051 $3,573 $4,257 $4,805
Interest Income (M) $64 $59 $65 $141 $190 $195
Operating Margins 22% 24% 25% 25% 27% 27%
Net Margins 17% 18% 19% 19% 20% 21%
Net Income (M) $399 $480 $587 $672 $871 $993
Depreciation & Amort. (M) $23 $26 $33 $39 $40 $44
Diluted Shares (M) 275 276 277 279 281 284
Earnings Per Share $1.45 $1.74 $2.12 $2.41 $3.1 $3.5
EPS Growth n/a 20.0% 21.84% 13.68% 28.63% 12.9%
Avg. Price $32.48 $41.99 $53.78 $63.5 $71.11 $82.38
P/E Ratio 22.87 24.56 25.86 26.68 23.24 23.74
Free Cash Flow (M) $605 $642 $764 $829 $941 $1,092
CAPEX (M) $73 $71 $45 $52 $69 $82
EV / EBITDA 18.48 20.5 20.78 23.46 20.14 19.98
Total Debt (M) $1,610 $2,166 $2,065 $4,193 $4,365 $4,049
Net Debt / EBITDA 1.94 2.32 1.72 3.87 3.09 2.5
Current Ratio 1.22 1.26 1.25 1.09 1.04 1.1

Brown & Brown benefits from rapidly growing revenues and a flat capital expenditure trend, strong operating margins with a stable trend, and generally positive cash flows. The company's financial statements show a strong EPS growth trend and reasonable leverage levels. Furthermore, Brown & Brown has just enough current assets to cover current liabilities, as shown by its current ratio of 1.1.

Brown & Brown's Valuation Is in Line With Its Sector Averages:

Brown & Brown has a trailing twelve month P/E ratio of 28.2, compared to an average of 15.92 for the Finance sector. Based on its EPS guidance of $4.09, the company has a forward P/E ratio of 22.8. Brown & Brown's PEG ratio is 2.33 on the basis of the 12.1% weighted average of the company and the broader market's EPS compound average growth rates. This suggests that the company's shares are overvalued. Furthermore, Brown & Brown is likely overvalued compared to the book value of its equity, since its P/B ratio of 2.19 is higher than the sector average of 1.78. The company's shares are currently trading 90.4% below their Graham number. In conclusion, Brown & Brown's impressive cash flow trend, decent P/B ratio, and reasonable use of leverage demonstrate that the company may still be fairly valued — despite its elevated earnings multiple.

Brown & Brown Has an Average Rating of Buy:

The 12 analysts following Brown & Brown have set target prices ranging from $92.0 to $135.0 per share, for an average of $107.5 with a buy rating. The company is trading -25.2% away from its average target price, indicating that there is an analyst consensus of strong upside potential.

Brown & Brown has an average amount of shares sold short because 3.5% of the company's shares are sold short. Institutions own 81.2% of the company's shares, and the insider ownership rate stands at 13.21%, suggesting a large amount of insider shareholders. The largest shareholder is Vanguard Group Inc, whose 11% stake in the company is worth $2,865,700,988.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS